CVR number 38118722
Industry 869500

Aalborg Neuro Klinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.6% 12.0% 11.9% 9.5% 10.3%  
Credit score (0-100)  18 19 19 25 24  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  178 166 286 177 8.7  
EBITDA  178 166 286 177 8.7  
EBIT  156 144 286 177 8.7  
Pre-tax profit (PTP)  154.5 140.4 283.1 174.7 6.2  
Net earnings  120.3 108.0 220.5 135.3 3.9  
Pre-tax profit without non-rec. items  154 140 283 175 6.2  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  22.0 0.0 0.0 0.0 0.0  
Shareholders equity total  183 178 299 316 198  
Interest-bearing liabilities  0.0 0.0 0.0 3.0 3.1  
Balance sheet total (assets)  407 314 434 451 456  
Net Debt  -346 -269 -401 -412 -179  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  178 166 286 177 8.7  
Gross profit growth  47.2% -6.9% 72.4% -38.0% -95.1%  
Employees  2 2 2 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  407 314 434 451 456  
Balance sheet change%  -3.1% -23.0% 38.4% 3.9% 0.9%  
Added value  178.4 166.0 286.2 177.5 8.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -44 -44 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  87.7% 86.7% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  37.8% 40.0% 76.5% 40.1% 1.9%  
ROI %  95.8% 79.7% 119.9% 57.4% 3.4%  
ROE %  73.7% 59.7% 92.4% 44.0% 1.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  45.0% 56.8% 68.8% 70.1% 43.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -194.1% -162.0% -140.3% -232.4% -2,055.0%  
Gearing %  0.0% 0.0% 0.0% 1.0% 1.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 182.0% 81.9%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.6 2.1 3.0 3.2 1.7  
Current Ratio  1.7 2.3 3.2 3.3 1.8  
Cash and cash equivalent  346.3 268.9 401.4 415.5 182.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  161.4 178.4 298.9 316.4 198.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  89 83 143 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  89 83 143 0 0  
EBIT / employee  78 72 143 0 0  
Net earnings / employee  60 54 110 0 0